Cargando…
YYFZBJS ameliorates colorectal cancer progression in Apc(Min/+) mice by remodeling gut microbiota and inhibiting regulatory T-cell generation
BACKGROUND: Progression of Colorectal cancer (CRC) is influenced by single or compounded environmental factors. Accumulating evidence shows that microbiota can influence the outcome of cancer immunotherapy. T cell, one of the main populations of effector immune cells in antitumor immunity, has been...
Autores principales: | Sui, Hua, Zhang, Lu, Gu, Kaijuan, Chai, Ni, Ji, Qing, Zhou, Lihong, Wang, Yan, Ren, Junze, Yang, Limei, Zhang, Bimeng, Hu, Jing, Li, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367414/ https://www.ncbi.nlm.nih.gov/pubmed/32677955 http://dx.doi.org/10.1186/s12964-020-00596-9 |
Ejemplares similares
-
The Effects of Berberine on the Gut Microbiota in Apc (min/+) Mice Fed with a High Fat Diet
por: Wang, Huan, et al.
Publicado: (2018) -
Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc(min/+) mice
por: Li, Lu, et al.
Publicado: (2019) -
Apigenin remodels the gut microbiota to ameliorate ulcerative colitis
por: Fu, Rongrong, et al.
Publicado: (2022) -
Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020) -
Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APC(Min/+) Mice
por: Son, Joshua S., et al.
Publicado: (2015)